Nitric oxide synthase (NOS), the enzyme that catalyzes the formation of nitric oxide from Larginine, exists in three major isoforms, neuronal, endothelial, and immunologic. Neuronal and endothelial isoforms are constitutively expressed, and require calcium for activation. Both of these isoforms can be induced (i.e., new protein synthesis occurs) under appropriate conditions. The immunologic isoform is not constitutively expressed, and requires induction usually by immunologic activation; calcium is not necessary for its activation. Neuronal and immunologic NOS have been detected in the retina. Neuronal NOS may be responsible for producing nitric oxide in photoreceptors and bipolar cells. Nitric oxide stimulates guanylate cyclase of photoreceptor rod cells and increases calcium channel currents. In the retina of cats, NOS inhibition impairs phototransduction as assessed by the electroretinogram. Inducible nitric oxide synthase, found in Muller cells and in retinal pigment epitheliums, may be involved in normal phagocytosis of the retinal outer segment, in infectious and ischemic processes, and in the pathogenesis of diabetic retinopathy. Nitric oxide contributes to basal tone in the retinal circulation. To date, findings are conflicting with respect to its role in retinal autoregulation. During glucose and oxygen deprivation, nitric oxide may increase blood flow and prevent platelet aggregation, but it may also mediate the toxic effects of excitatory amino acid release. This reactive, short-lived gas is involved in diverse processes within the retina, and its significance continues to be actively studied. Copyright 01996
INTRODUCTION
Nitric oxide (NO), a gas with a half-life of a few seconds , has diverse physiological functions, the nature of which have been elucidated primarily in the past 5 or 6 years. Three important systemsin which NO acts as a messengermolecule are in white blood cells, where it mediates cytotoxiceffects; in blood vessels, where it acts as endothelial-derived relaxant factor (EDRF); and in the central nervous system, where NO acts as a neurotransmitter .Within the central nervous system, NO is also involved in diverse processes such as neurotoxicity (Dawson, 1994) , microphage and neutrophil-mediated cytotoxicity (Kuo & Schroeder, 1995) , platelet aggregation (Stewart et al., 1994) , blood flow (Faraci & Brian, 1994) , synaptic transmission , and long-term potentiation (Haley et al., 1992) .
In the retina, nitric oxide synthase (NOS) is found in retinal neurons, pigment epitheliums (Bredt et al., 1990; Goureau et al., 1993b) , amacrine and ganglion cells (Dawson et al., 1991a; Koistinaho et al., 1993; Yamamoto et al., 1993b) , nerve fibers in the outer and inner plexiform layers, and in photoreceptor ellipsoids (Yamamotoet al., 1993a) .The optic nerve of normal rats was devoid of NOS (Yamamoto et al., 1993a) . Evidence is now emerging that NO is a mediator of physiological,and possiblypathological,processesin the retina. The finding that NO modulates voltage-gated ion channels in rod photoreceptorssuggeststhat NO may be involved in photoreceptor light transduction and photoreceptor synaptic output (Kurenny et al., 1994) . Results of both in w"troand in vivo studies in different animal species suggest that NO is involved in the control of retinal blood flow under basal conditions (Deussen et al., 1993; Seligsohn& Bill, 1993; Toda et al., 1994; Wiencke et al., 1994) and followingretinal ischemia (Goldsteinet al., 1995; Veriac et al., 1993) .Diabetic vascular damage in the retina may be mediated in part by NO (Tilton et al., 1993) and the enhanced expression of NOS by retinal glial cells and pigment epitheliums in response to lipopolysaccharide,interferon, and tumor necrosis factor indicates a role for NO in the development of, or \ protection from, infection in the retina (Goureau et al., 1994a, b) . Accordingly, we will review the sources and synthesis of NO, and the evidence that it is involved in various processes in the retina, both under normal conditions and in disease.
because of its unpaired electron, and is poorly soluble in water. Its half-life in biological tissue varies from 10 to 60 sec but may be prolonged to 4 min in the absence of tissue and in the presence of oxygen (Kiechle & Malinski, 1993) .
NO readily diffuses across cell membranes and has no known storagemechanism.Many vasodilatorsexert their effects on vascular smooth muscle by activating endothelial NOS, releasing NO (EDRF) to the vascular smooth muscle (Schmidt & Walter, 1994) . NO reacts with ferrous iron in the heme prostheticgroup of soluble guanylate cyclase. The resulting increase in cyclic GMP relaxes vascular smooth muscle and inhibits platelet adhesion and aggregation (Moncada & Higgs, 1993) .
Nitric oxide synthase: Retinal localization and characterization
NADPH diaphorase, a histochemicalenzymatic activity that reduces tetrazolium dyes in the presence of NADPH, but not NAD, has been used as a marker for the presence of NOS in the retina (Dawson et al., 1991a) . NADPH diaphorase staining is present throughout the visual system, indicating the widespread presence of NOS (Vincent& Hope, 1992) .In rats and in mice, retinal NOS is found predominantly in amacrine cells, in displaced amacrine cells in the ganglion cell layer, in other cells in the inner nuclearlayer, and in nerve fibersin the outer and inner plexiform layers (Huang et al., 1993; Yamamoto et al., 1993b) . Ca2+/calmodulin-dependent NOS activity was induced in retinal ganglion cells, in axons in the retinal nerve fiber layer, and in the optic nerve of rats by pterygopalatineparasympatheticdenervation (Yamamoto et al., 1993a) . NOS has not been found in the retinal nerve fiber layer or in optic nerve axons. Human retinal tissues have been found to express mRNA for both cNOS and iNOS (Park et al., 1994) .The discovery of NOS activity (both by diaphorase staining and by Northernblot analysisusing a cDNA probe) in the developing chick tectum in proximity to retinal axons (Williamset al., 1994) suggeststhat NOS may also play a role in retinal development. The isoforms of NOS possibly involved in this synaptogenesis have not yet been elucidated.
The presence of cNOS activity in the photoreceptorsis controversial. Although the studies using immunocytochemical and NADPH diaphorasehistochemicalstaining failed to localize NOS activity within photoreceptors, other investigators have detected cNOS activity in extracts of bovine photoreceptor outer segments. These discrepanciesmay be due to differences in experimental conditions, or insensitivity of NADPH diaphorase staining. In one study, NOS activity of photoreceptors was assayed indirectly,by measuring the rate of change in absorption of oxyhemoglobin as it was oxidized to methemoglobin by NO. These authors determined that the enzyme was Ca2+-and calmodulin-dependent, required NADPH, used L-arginineas substrate, and was inhibited by L-arginineanalogs (Venturini et al., 1991) . These propertiesof the retinal enzyme are those expected of a cNOS. Other investigatorsused anti-NOSantibodies, and localized cNOS in ellipsoid regions of bovine inner, but not outer, photoreceptorsegments.Solubleguanylate cyclase, a target enzyme for NO, was localized in nearby cell bodies of cone photoreceptor cells (Koch et al., 1994) .These findingssuggest,but do not prove, that NOS may have a neuromodulatoryrole in visual transduction (see below, 'Nitric Oxide and Visual Transduction'). Further studies are required to precisely localize and characterize the function of NOS in photoreceptors.
iNOS activity has been found within cells of the retina and, althoughnot yet examined there, is probablypresent within macrophages and neutrophils residing in the ocular circulation. At present, the control and function of retinal iNOS are still incompletelydefined,and there is controversy about the role of various mediatorsof iNOS, Cultured bovine retinal pigment epithelial (RPE) cells produced NO upon treatmentwith interferon(IFN) in the presence of lipopolysaccharide(LPS) and tumor necrosis factor (TNF). Approximately 12 hr was required for induction of NO production, and its synthesis continued for 96 hr (Goureau et al., 1992) .Mediationby cytokines, slow onset and prolonged release of NO are consistent with the propertiesof iNOS in other tissues.WhetherIFN or IFN-inducing agents like LPS exert effects upon retinal iNOS that are at the transcriptional or posttranscriptional level is not yet known. Transcriptional induction of iNOS by these cytokines has only been shown so far in mouse macrophages (Nathan & Xie, 1994b) ,and perhaps retinal iNOS is controlled similarly. RPE iNOS was inhibited by dexamethasone, cycloheximide, and L-arginine analogs (Goureau et al., 1992) . Inhibition by dexamethasonemay be via a post-translational effect, as the iNOS promoter does not possess steroid recognition sites (Nathan & Xie, 1994b) .
The effects of cytokines on RPE iNOS activity are complex. Fibroblast growth factor inhibits NOS in cultured bovine RPE, while transforming growth factor P (TGF-jl) enhances iNOS activity (Goureau et al., 1993b) . NO itself may have an anti-proliferativeeffect; nitriteor citrullineproductionfrom the cellswas inversely correlatedwith the level of cellularproliferation (Goureau et al., 1993b) . Phagocytosisof retinal rod outer segments (ROS) by bovine RPE cells was inhibitedboth by SIN-1, which releases NO, and by endogenousNO released by cytokine-stimulatedRPE cells. This effect was antagonized by NO scavengers (hemoglobin) or, L-arginine analogs and was not dependentupon cGMP (Becquet et al., 1994) , as expected of an iNOS. Perhaps the physiologicalrole of iNOS in the RPE is to contributeto phagocytosisof the rod outer segmentsthroughrelease of NO; further studies are necessaryto test this hypothesis.
Cultured human RPE cells also possess an iNOS, with properties like those of the bovine RPE enzyme. However, differentmediatorsregulateNOS in the human cells, Human RPE cells required both interleukin-1~and IFN to produce NO, and LPS did not increase NO production. TGF-fl strongly inhibited NO production from human, but not bovine, RPE .Perhapsthe differencein the effectsof regulatorsis due to differingexpressionof receptorsubtypesin various cells or from the same cells of different species. It is not known at what level of NOS expressionTGF-/?exerts its effectsin the retina. In murinemacrophages,TGF-flacted at multiplelevels, inhibitingiNOS translation,destabilizing iNOS mRNA, and accelerating the degradation of iNOS protein (Nathan & Xie, 1994b) .The recent cloning of the human iNOS gene may allowus to soon understand these mechanismsmore fully (Billiar, 1995) .
Production of NO by activated macrophages is an important cytostatic/cytotoxic defense mechanism against microorganisms. NO acts on a number of important biochemical pathways in microbes, including aconitaseof the tricarboxylicacid cycle, complex I and II of electron transport, and glyceraldehyde-3-phosphate dehydrogenase. All of the enzymes affected by NO containcatalyticallyactivenon-hemeiron bound to sulfur atoms.NO forms Fe-nitrosylcomplexes,which inactivate these enzymes, leading to death of the cells (Kuo & Schroeder, 1995) . Inhibition of ribonucleotidereductase (the rate-limiting enzyme of DNA synthesis), direct chemical action upon DNA, and the formation of toxic oxygen free radical species are additional known toxic effects of NO upon microbes (Morris & Billiar, 1994) . iNOS expression may be beneficial (e.g., in the presence of bacterial infection, where release of NO could lead to killing of microbes), or may be harmful (e.g., autoimmune disease, or septic shock). At present, little is known about the role of iNOS expression in retinal pathology. Of interest is the finding that an iNOS inhibitor decreased endotoxin-induced uveitis in rats (Tilton et al., 1994) ,providing the first evidence that NO is involved in ocular inflammation. Also, TGF-fl (detected in aqueous humor) inhibited uveitis. Accordingly, it is interestingto speculate that TGF-/l and iNOS interact in regulating ocular inflammation. Such an interaction may have important clinical significance in the pathophysiologyof various eye diseases.
RPE cells are not the only retinal cells in which iNOS has been detected. iNOS activity was also found in Miiller glial cells of the rat retina (Goureau, D. et al., 1994) ; these cells produced nitrite within 12 hr of exposure to the mediators IFN, TNF, and LPS. iNOS mRNA isolated from Miiller cells was similar in size to that of microphage iNOS. TGF-fl inhibited cytokinemediated NO production. Recently, NOS activity was detected in cytomegalovirus-infectedglial cells, particularly Miillercells, in patientswith AIDS (Dighiero et al., 1994) . This is further evidence that iNOS is an immune modulator in the retina. However, it is not known if this increased iNOS expression is a marker of infection or a component of the pathophysiology of infection. Also, whether iNOS confers protection or greater sensitivityto viral infectionis not clear. It is knownthat NO suppresses T lymphocyteproliferationand cytolysis.This may result in increased sensitivity to viruses during chronic inflammation (Schmidt & Walter, 1994) .
NO is most likely involved in retinal blood flow regulation (see below). Accordingly, NOS immunoreactive nerve fibers were found in peripheral ocular tissues, particularlyin the choroidand aroundlimbalbloodvessels (Yamamoto et al., 1993b) .These findingsare consistent with a role for NOS in ocular blood flow regulation, although these studies have yielded controversialresults (see below). Most human choroidal nerve fibers were found to stain for NOS (Fliigelet al., 1994) .These nerve fibers are predominantly derived from the ipsilateral pterygopalatine ganglion. The choroid is more heavily innervatedwith NOS nerve fibersin the temporal+entral region than in the foveal region, perhaps reflecting the need for greater circulatorycontrol of that area (Fliigelet al., 1994) .Virtually all NOS immunoreactivepterygopalatine-derived nerve fibers also stained positively for vasoactive intestinal polypeptide and many also colocalized with neuropeptideY in some of the neurons of this ganglion. The nerve fibers probably serve as parasympatheticmediatorsof choroidalvasodilatation,exerting their effects through productionof NO. The anterior peripheral ocular circulation was much less heavily innervated. NOS-containing nerve fibers in the ciliary body were chieflyfound adjacentto the circulation,rarely found in the iris, and were not present in the cornea. The vascularendotheliumin the choroid,limbus,irisand retina were NOS-immunoreactive (Yamamotoet al., 1993b) .
MEASUREMENTOF NITRIC OXIDE CONCENTRATION
To study the biological role of NO in a particular process requires measuring its concentration.Due to its reactivityand brief half-life,measuringNO concentration in animal models has posed a serious challenge to investigators. As a result, NO concentrationhas generally been inferred indirectly,based on readilyobservedeffects such as productionof citrullinefrom L-arginine,determination of nitrite concentration,increased cGMP concentration, vasodilatation (Kiechle & Malinski, 1993; Moncada & Higgs, 1993) or by studying the effects of inhibitionof NOS. Of these methods,only the concentrations of cGMP or of citrulline yield quantitative information regardingthe amountof NO produced (Kiechle& Malinski, 1993) . Direct measurement of NO concentration would be far preferable to these approaches.NO can be measured directly using spectroscopicor electrochemical means. These methods, and their advantages and disadvantages have been reviewed recently (Kiechle & Malinski, 1993) . Application of direct measurement of NO concentration in vivo has recently been performed using a NO-sensitive microelectrode positioned in the cerebral cortex (Malinskiet al., 1993) .This is an exciting technology that could yield considerable information abciutNO release in intact organs.
Perhaps the most common means used to assess the involvement of NO in a process is the use of NO synthesisinhibitors,such as the L-arginineanalogs, or of molecules which may combine with and thereby deactivateNO, such as hemoglobin.The most frequently used NOS inhibitors are the L-arginine.analogsnitro-Larginine methyl ester (L-NAME), N-monomethyl Larginine (L-NMA),and nitro-L-arginine(L-NA) (Nathan, 1992) .The mechanismsby which these agents inactivate the enzyme are not clear. Covalentbonding between the inhibitorand NOS is one proposedmechanism (Dwyer et al., 1991) .In brain preparationsfrom rats treated with L-NA or L-NMA, irreversible inhibition of NOS has been observed. These animals had received high doses of inhibitorfor at least 4-7 days (Dwyer et al., 1991) . Klatt et al. (1994) studied the binding of L-NA and L-NMAto NOS purifiedfrom porcinebrain. NOS was inhibitedby 5 min pre-incubation with 10 pm concentration of either inhibitor. Yet, activity was restored by dilution with Larginine after 1 min for L-NMA,and after 30 min for L-NA. This suggested a faster dissociation of the L-NMA complex than its L-NA counterpart. Although the mechanism of this effect is not known, it appears that access of L-NMA to NOS is impaired by its bulky and polar methyl group.
Because of lack of selectivity, L-alginine analogs cannot distinguishbetween iNOS and cNOS, or between endothelial and neuronal NOS. In cell culture or in isolated blood vessels, aminoguanidineprovided selective competitive inhibition of iNOS (Joly et al., 1994; Misko et al., 1993) . In mice, 7-nitroindazoleselectively inhibited neuronal, but not endothelial NOS . Use of these compounds in vivo may allow investigators to evaluate the effects of specific NOS isoform inhibition. However, little is known still about the dose-responseeffects of these agents, and it is quite possiblethat specificitymay be dose-dependentin in vivo experiments.
A disadvantageof using L-arginineanalogsis that they exert other significant effects, which may obscure the physiological role of NO in a given experimental paradigm. For example, in isolated strips of coronary artery or colonic smoothmuscle of rabbits, L-NAMEand other L-arginine analogs containing carboxy terminal alkyl ester substitutions functioned as muscarinic antagonists (Buxton et al., 1993) . Carboxy groups in L-NAME and L-NMA may bind iron atoms. Accordingly, in vitro, these compoundsinhibitedthe reductionof ferric cytochrome c by ferrous iron, fatty acid-oxygen-iron complex transfer of electrons to cytochrome c, and the reduction of ferric cytochrome c by epinephrine (Peterson et al., 1992) .In experimentstesting the involvement of NO during oxygenand glucosedeprivation(ischemia), L-arginineanalogs may further decrease normal aerobic metabolism and inhibit post-ischemic recovery by inhibitionof mitochondrialenergy production.However, the physiological significance of the in vitro data is questionablebecause NOS inhibitorsdo not affect resting cerebral glucose utilization or oxygen consumption Kozniewska et al., 1992; McPherson et al., 1994) .
Finally, an undesirable effect that accompanies systemic administration of L-arginine analogs is endothelial NOS inhibition, resulting in an increase in arterial blood pressure. This effect is apparently due .to a decrease in EDRF, which is responsible for the maintenance of normal vascular tone, although there is evidencethat a central effect may increaseblood pressure (Togashi et al., 1992) . Specific iNOS inhibitors did not alter arterial blood pressure , and are clearly a better choice in experiments in intact animals.
NITRIC OXIDEAND VISUALTRANSDUCTION
cGMP in visualprocessing 3'-5'cyclic guanosinemonophosphate(cGMP) is a key intermediate in the visual transduction cascade. Production of cGMP from GTP is catalyzed by guanylate cyclase (GC), a target enzyme for the action of NO (Waldman & Murad, 1987) . In photoreceptor outer segments, cGMP controls ionic fluxes across the plasma membrane by opening a specialized species of ion channels, the cGMP-gated, non-selective cation channels. Absorption of light by visual pigments in rods and cones triggers a cascade of eventsthat eventuallyleads to a change in ionic fluxesacross the plasma membrane and a consequent change of membrane potential (Koch, 1992) .cGMP-gatedconductance have been found in the inner and outer segmentsof the photoreceptor (Watanabe & Matthews, 1988) . cGMP-gated channels are also present in bipolar cells (Nawy & Jahr, 1991; Shiells & Falk, 1990) ,horizontalcells (DeVries & Schwartz, 1988; Miyachiet al., 1991) and in ganglioncells (Ahmad et al., 1994) ,but their role and regulation in these cells are not yet well understood.
Briefly summarized, phototransduction occurs in several stages: (1) Light absorption changes the 11-cis retinal within rhodopsin into the all-trans configuration.
(2) Activated rhodopsin(metarhodopsinII) activatesa Gprotein (transducing) that activates a cGMP phosphodiesterase (PDE). (3) This leads to reduction of intracellular cGMP concentration via PDE-mediated hydrolysis of cGMP to 5'GMP. (4) cGMP-gated Na+ channels close and the photoreceptor cell hyperpolarizes. (5) cGMP concentration is restored through resynthesis by guanylate cyclase (GC) (Gorczycaet al., 1994) and possiblyby inactivation of the phosphodiesterase (Kawamura & Murakami, 1991) . It is believed that the reduction of the intracellularCa2+concentrationmediates the restoration of cGMP levels by a negative feedback loop (Koch, 1992; Lagnado & Baylor, 1992; Pugh& Lamb, 1993) .
Guanylate cyclase, the enzyme that catalyzes formation of cGMP from GTP, existsin two isoforms:a soluble and a particulateform. Both isoformshave been shown to exist in the retina. Four differentclassesof particulateGC (pGC) have been identified: atrial natriuretic peptide receptor type A and B, guanylyl cyclase C and retinal cyclase. All have in common that they are membrane bound and have, in addition to their intracellular GC catalytic domain, a large extracellular domain with receptor-like ligand binding activity. For a review see Schmidt et al. (1993) .
ParticulateGC is foundprimarily in rod photoreceptors (Ahmad & Bamstable, 1993; Horio & Murad, 1991; Waldman & Murad, 1987) .Rod outer segment(ROS) GC is tightly associated with the cytoskeleton (Hakki & Sitaramayya, 1990) . Particulate GC is a single polypeptide chain of 150 kDa containing a binding site for atrial natriuretic factor (Lowe et al., 1989) . In addition to particulate GC, rods also contain a soluble GC, which is found in the cytoplasm (Margulis et al., 1992) . Using in situ hybridization,soluble GC was found throughoutthe rat retina, with the greatest quantitiespresent in the inner nuclear layer; particulate GC predominated in the rod photoreceptors. Actual enzyme activity, however, was not determined in this study (Ahmad & Barnstable, 1993) . Soluble GC is a heterodimer of 70 and 82 kDa subunits;interaction of NO or oxygen free radicals with heme groups of both subunits leads to activation of the enzyme (Ignarro, 1990) . Both subunits are required for regulation of activation and basal enzyme activity (Buechler et al., 1991) .
Possible role of nitric oxide in photoreceptors
There are two possible functions of NO in photoreceptors: modificationof light responsesin photoreceptors, and modulation of synaptic transmission from photoreceptors to bipolar and horizontal cells. These functions may be mediated by effects of NO on GC or other target enzymes or proteins in the retina.
Recent studiesusing combined immunohistochemistry and/orbiochemicalcharacterizationlocated NOS activity mainly in rod inner segments (Koch et al., 1994; Kurenny et al., 1994; Yamamoto et al., 1993b) .Location of NOS activity in close proximity to the GC target enzyme makes NO a likely, although still unproven, effecter molecule in photoreceptors. High levels of cGMP are known to exist in photoreceptors (Ferrendelli & Vries, 1983) and cGMP immunoreactivitywas increased by the NO donor sodium nitroprusside (Berkelmans et al., 1989) , indicating the existence of a NO-sensitive GC in photoreceptors.In isolated frog rods, decrease in cGMP concentration led to a hyperpolarization of the dark voltageand a prolongationof lightresponses,which were not reversiblewith donationof GTP. Additional application of the NO donor SNP normalized dark current and light response, indicating that cGMP concentration was increasedvia stimulationof a GC by NO (Schmidtet al., 1992) . A similar finding was observed when L-arginine was co-applied with the NOS cofactor NADPH to isolated frog rods (Tsuyama et al., 1993) .These findings suggest that NO may be able to increase cGMP concentration in photoreceptor outer segments, thereby increasingcGMP-gated conductance and altering visual transduction.However, these results in isolated invertebrate cells have yet to be confirmedin vertebrate animals.
Retinal GC, which is insensitiveto NO and represents the major fraction of GC activity (Marguliset al., 1992) , is found in ROS and was shown to be involvedin cGMP synthesisafter light response (Dizhoor et al,, 1994) . So far, retinal GC is thought to be activated by a soluble activator that acts as a Ca2+sensor. But these experimental results are controversialand suggest the possibi- (1994) . In the outer segments (OS), decreased Ca2+concentration following light stimulation leads to activation of particulate GC (pGC). Activation of pGC is mediated by calcium binding protein (CaBP). Production of cGMP (which acts upon cationic channels) from GTP results in recovery of the photoresponse.In the inner segments,NOS is activated at increased Ca2+concentration,via the action of calmodulirr(CaM). The resulting NO which is produced could have multiple effects, includingstimulationof solubleGC (sGC), and modulationof synaptic transmission from the photoreceptor.Diffusion of NO to nearby cells may have effects upon bipolar cells (GC activation) or may control hemi-gap junction channels in horizontal cells. NO may diffuse into outer segments to stimulate ADP-ribosylationof OS proteins.
lity that other factorsbeside Ca2+may in fact be involved in the regulation of retinal GC (Coccia & Cote, 1994) . Isolated rod outer and inner segments were shown to containan NO-sensitivesGC (Koch et al., 1994; Margulis et al., 1992) . However, this sGC only represents a small fraction of the total GC activity (Marguliset al., 1992) . Particulate GC was unresponsiveto nitroprusside,and thus to NO (Horio & Murad, 1991) . cGMP increases in isolated rods in response to NO and nitroprusside application may therefore be attributable to sGC (Schmidt et al., 1992) . However, in bovine retina extracts, NOS was found only in outer segmentsattached to parts of inner segments (band II of rhodopsin, i.e., ellipsoid),but not in pure outer segment extracts (band I of rhodopsin); sGC was detected primarily in band II, with very little activity in pure outer segments.Although NO may activate GC of rods and induce depolarization, such activity has yet to be demonstrated in conjunction with endogenousNO production.Thus, NO involvement in control of cGMP in outer segments remains speculative (Koch et al., 1994) . Further, due to the Ca2+ dependence of cNOS, and the decrease in the photoreceptor concentrationof Ca2+during the light response, the degree of NOS activity in the photoreceptorcell is in question. With the light response, Ca2+concentration in the photoreceptormay decrease to 140 nM, which is in the range of Ca2+ sensitivity for GC activity (Koch, 1992) .Brain cNOS is approximately20% of its maximal activity at a free Ca2+concentrationof 140 nM (Knowles et al., 1989) . No data are available yet on the Ca2+ dependence of photoreceptor NOS. Possible effecter responsescausedby NOS of photoreceptors,theorizedby Koch (Koch et al., 1994) , are summarized in Fig. 1 .
In addition to its effects upon GC, NO effects in photoreceptorsmay be mediated through other mechanisms. NO has been shown to increase adenosine diphosphate (ADP) ribosylationof a variety of proteins (Bribe & Lapetina, 1990; Zhang et al., 1994) such as transducing and G-protein and other, yet unidentifiedproteins in the ROS (Ehret-Hilberer et al., 1992; Pozdnyakov et al., 1993) . NO-mediated post-translational modification of cellular proteins may be a mechanism that alters activation and deactivation of enzymes in the visual transductioncascade of the ROS.
NO maybe involvedin synaptictransmissionfrom the photoreceptors. Recently, the effect of NO on rod photoreceptor ion channels was investigated. In salamander retina, NOS was detected in photoreceptor ellipsoids and distal portions of bipolar and glial cells in proximity to photoreceptorinner segments. The NOreleasing compound SNC, when applied to isolated salamanderphotoreceptors,increased both Ca2+channel current, which is involved in mediating photoreceptor synapticoutput, and a voltage-independentconductance, involvedin generatingphotocurrentsin the outer segment (Kurenny et al., 1994) . Ca2+ currents, either voltagegated or cGMP-gated, have also been shown to initiate exocytosis at cone synapses (Rieke & Schwartz, 1994) . Thus, the NO-dependent Ca2+ current may modulate output at photoreceptor synapses, thereby affecting transmissionof the photoresponseto the bipolar cells.
POSSIBLE ROLE OF NITRIC OXIDE IN BIPOLAR, AMACRINE,HORIZONTAL,AND GANGLIONCELLS
NO donors or NOS inhibitors modified electrical coupling in horizontal cells (DeVries & Schwartz, 1988; Miyachi et al., 1991) and altered cGMP-gated synaptic conductance in ganglion cells (Ahmad et al., 1994) .However, a distinctfunctionalrole of NO remains to be demonstrated.Three possible functions of NO will be reviewed: (1) modificationof light responses in ONbipolarcells; (2) effects upon electricalcouplingbetween horizontal cells; and (3) alteration of electrical excitability of ganglion cells.
Cone ON-bipolar cells transmit light responses of cone-photoreceptors to ganglion cells. In the dark, photoreceptorsrelease relatively high amounts of glutamate into the synapticcleft, which bind to a metabotropic glutamate receptor present in ON-bipolar cells (for review see Barnstable, 1993) . Activation of the receptor is thought to activate a G-protein, which activates a phosphodiesterase hydrolyzing cGMP (Nawy & Jahr, 1990 Shiells & Falk, 1990) . Consequently,with a decrease in cGMP-concentration, cGMP-gated cation channels close and the ON-bipolar cell hyperpolarizes (Nawy & Jahr, 1990 Shiells & Falk, 1990) . Followinglight stimulation,cones release less glutamate, which leads to an increase in cGMP in ON-bipolar cells and, after opening of cGMP-gated cation channels, to a depolarizationof ON-bipolar cells (Nawy & Jahr, 1990 Shiells & Falk, 1990) . Although there are many similaritiesto the light response of photoreceptors,there are also important differences. Bipolar cells, express a different cGMP-gated channel than photoreceptors (Shiells & Falk, 1992b; Wassle et al., 1992) . The guanylate cyclase responsible for cGMP production differs between ROS and ON-bipolar cells. Retinal GC, located in ROS, is assumed to be a particulate form (Ahmad & Barnstable, 1993) . The GC of ON-bipolar cells is an NO-sensitive sGC (Ahmad & Barnstable, 1993; Shiells & Falk, 1992a) . Accordingly, cGMP immunoreactivityincreased in ON-cone bipolar cells of rabbit retina after application of NO-donors (Koistinaho et al., 1993) .Amacrine cells, which are NADPH positive and in close proximityto ON-bipolarcells, are thereforea possible source of NO to activate sGC in these cells (Koistinaho et al., 1993) .
Once NO has entered ON-bipolarcells it may not only act upon sGC, but also initiateADP-ribosylation.In fact, like transducing in photoreceptors,the G-protein coupled to the glutamatereceptorsin ON-bipolarcells is sensitive to ADP-ribosylation by pertussis-and cholera-toxin, identifying the G-protein in ON-bipolar cells as a possible target for NO-mediated ADP-ribosylation (Shiells & Falk, 1992b) .
In preliminary experiments in goldfish retina an NOdonor decreased inter-bipolar cell junctions, whereas L-NAME, a NOS inhibitor,enhancedthosejunctions (Sakai & Ball, 1994) . Therefore NO may also have an impact upon shape of the receptivefield of bipolar cells. Another way NO may alter synapticretinal transmissionis via an interactionwith dopamine,which is thoughtto modulate synaptic transmission from photoreceptors to OFFbipolar cells (Maguire & Werblin, 1994) . NO has been shown to decrease endogenous dopamine release in the retina via a cGMP-independentmechanism (Bugnon et al., 1994) .Thus, NO may also be involvedin modulation of synaptic transmissionto OFF-bipolarcells.
Extensive electrical coupling of horizontal cells via gap junctions is found in the retina. Modulation of electrical couplingcan alter receptivefield sizes and thus influence the lateral spread of light responses in the retina. Application of cAMP, cGMP, L-arginine,or the NO-donor SNP to horizontal cells decreased electricaland dye-tracer coupling between horizontal cells (DeVries & Schwartz, 1988; Miyachi et al., 1991) . Dopamine similarly decreased electrical coupling in horizontal cells (DeVries & Schwartz, 1988) , and since NO decreased dopaminerelease in the retina (Bugnon et al., 1994) , NO's effect on electrical coupling of horizontal cells may be mediated through dopamine. The cellular source of NO producing the decoupling effect could be either horizontalcells, photoreceptorsor amacrine cells. Horizontal cells are an unlikely source, since although NOS and NADPH diaphorase activity have been found in horizontalcells of the goldfishretina, such activity has not been demonstrated in higher vertebrates (Yamamoto et al., 1993b) . The existence of NOS in photoreceptors and amacrine cells has been shown as discussedearlier.
Ganglion cells are the output neurons of the retina. Since NADPH diaphorase activity is present within the ganglion cell layer, possibly from displaced amacrine cells (Liepe et al., 1994; Yamamoto et al., 1993b) , NO may modulate ganglion cell activity. Expression of mRNA coding for a soluble GC has been shown in the ganglion cell layer of rats (Ahmad & Barnstable, 1993) . Recently, the existence of a cGMP-gated non-selective cation channel, like that in photoreceptors, has been demonstratedin ganglioncells (Ahmad et al., 1994) .NO donors and a PDE inhibitor increased cGMP-gated conductance in ganglion cells, suggesting the presence of a NO-driven cGMP system in ganglion cells (Ahmad et al., 1994) . Ahmad has proposed a theory of how NO may act in ganglion cells (Fig. 2) . Amacrine cells in the ganglion cell layer synthesize NO that diffuses to ganglion cells. There it activates a sGC leading to an increase in cGMP concentrations.This in turn may alter ganglion cell membrane potential and intracellular ion concentrations(e.g., for Ca2+). Analogouslyto findingsin ON-bipolar cells, the possible existence of a G-protein coupled to a receptor activating or inactivating a PDE which hydrolyzes cGMP was postulated. However, the existence of such a mechanism in ganglion cells has not been shown. In conclusion,the role of NO in the control of the ganglion cell response remains speculative. Release of NO from amacrine cells stimulates GC of the ganglion cell. cGMP produced from GC acts upon cation channels in the ganglion cell. cGMP is degraded by phosphodiesterase (PDE). PDE activity is modulated by a G-protein, whose activity is modulated by a neurotransmitter released from bipolar cells which binds to R.
Effects of nitric oxide synthase inhibition on the electroretinogram
Recent studies in our laboratoryon the effects of NOS inhibitionon the electroretinogram(ERG) in cats provide the first evidence of NO involvementin visual transduction in intact vertebrate eyes . L-NAME, 30 mgkg was given intravenouslyto adult cats, and NOS activitywas decreased90-95?4 in the retina and choroid. The dark-adapted ERG response to single 10 psec white light flasheswas measured.Both the a-and bwave amplitudeswere decreased significantlycompared to saline-injectedcats starting 1 hr after L-NAMEadministration,and 6 hr later, the a-and b-wave amplitudeswere 64% and 51% of pre-L-NAME baseline, respectively. These effects on the ERG were completely reversed by intravenous administrationof L-arginine(200 mg/kg/hr) . Since the b-wave was affected more profoundly than the a-wave, perhaps NOS is of greater importance in inner retinal, rather than photoreceptorrelated events in the visual transduction pathway. This speculationcould be answered perhapsby performingrecordingsin the vicinity of specificcell populations,rather than the whole retina ERG. These findings also suggest the need for further studies, perhaps using microelectrodes to measure NO release or the effects of specific NOS inhibitorson the visual transductionpathway.
NITRICOXIDEAND THE REGULATIONOF RETINAL BLOOD FLOW
The cerebral and retinal vasculature share many similarities.Sincerelativelymore informationis available on the role of NO in the regulationof cerebral blood flow (CBF) than of retinal blood flow, it is useful to briefly review studieson the role of NO in the controIof cerebral circulation. NO functions as a vasodilatorin responseto local stimuli within the cerebral circulation (Moncada & Higgs, 1993) . Furchgott & Zawadzki (1980) suggested that NO was EDRF, responsiblefor mediatingthe effects of acetylcholine on vascular smooth muscle. EDRF produces vasodilatation when NO binds to the heme component of soluble GC located in vascular smooth muscle (Moncada & Higgs, 1993) .Heme groups of both subunitsof soluble GC must be bound by NO in order to activate the enzyme, which occurs when nitrosylationby NO displacesheme-ironout of the plane of the porphyrin binding site Ignarro, 1990) . The catalytic site of soluble GC is activated, resulting in increases in cGMP and relaxation of smooth muscle (Waldman & Murad, 1987) . The same mechanism operates to inhibitplatelet aggregation (Moncada, 1992) .
The NO that producesvasodilatationthrough action on vascular smoothmusclemay be synthesizedat sites other than endothelium. Alternate sites of NO production include NOS-containing perivascular nerve fibers and astrocytesadjacentto cerebralblood vessels (Bredt et al., 1990; Iadecola et al., 1993; Murphy et al., 1991; Nozaki et al., 1993) .
Neuronal activity is an important factor in the regulation of CBF. Thus, activation of the N-methyl-Daspartate(NMDA receptor,which is involvedin synaptic transmission)of rabbit brain increased CBF, but isolated cerebral arterioles did not vasodilate in response to NMDA. In vivo, NMDA-induced vasodilatation was attenuatedby NOS blockade, suggestingthat vasodilatation was mediated by neuronal, rather than endothelialproduced NO (Faraci & Breese, 1993) . There are conflicting data, however, on the effects of NOS inhibition on the CBF response to focal or global brain activation (Iadecola, 1993; .
BASAL TONE IN THE RETINALAND CHOROIDAL CIRCULATION
Several investigatorsexamined the role of nitric oxide and the endothelium in mediating the tone of isolated retinal or ophthalmic artery segments. In porcine ophthalmic artery segments, L-NMA produced endothelium-dependentcontractionswhich were reversed by Lbut not by D-arginine.L-NMA attenuated acetylcholineinduced relaxation in vessels with intact endothelium (Yao et al., 1991) . Relaxation of isolated retinal arteries in response to nicotine (Toda et al., 1994) , substance P (Kitamura et al., 1993) , and histamine (Benedito et al., 1991) appears to be mediated through the release of NO. Relaxation of isolated posterior ciliary arteries from the cow was decreased by NOS blockade and methylene blue, but was not altered by removal of the endothelium, suggesting that release of NO from perivascular nerves was responsiblefor vasodilatation (Wienckeet al., 1994) . In support of this hypothesis, nerve bundles containing NOS were detected in the adventitiaand media of the dog retinal artery (Toda et al., 1994) . Additional support for the involvementof NO was found using cultured bovine pericytes,which relaxed and producedcGMP in response to the NO donor, sodium nitroprusside.Responseswere blocked by methylene blue via inhibition of GC (Haefliger et al., 1994) . Further, relaxation of isolated human ophthalmicarteriesby NO has been demonstrated (Haefligeret al., 1992) .Thus in vitro studiessuggestthat retinal vascular tone may be regulated by NO both under basal conditions, as well as under pathological conditions, when vascular mediators may be released or the endothelium is damaged.
Studies examining the effects of NOS inhibition on ocular blood flow have yielded conflicting results. The effect of L-NAME on regional ocular blood flow was studied in anesthetized dogs. A dose of 20 mg/kg L-NAME iv. resulted in significant increases in mean arterial blood pressure, accompanied by 40-50?4 decreases in blood flow in the choroid,iris, and ciliary body without a significant change in retinal blood flow (Deussen et al., 1993) . Varying findings were reported when 300 mg/kg L-NAME was administered to rabbits. Blood flow decreased nearly 50% in all ocular tissues, including the retina (Seligsohn & Bill, 1993) . However, in cats 30 mg/kg L-NAME significantlydecreased blood flow in the iris, but not in the retina or choroid. In this study,L-NAME10mg/kg was sufficientto decreaseNOS activity by 90-95%in the retina and choroid .In the newborn pig, microsuffusionof L-NMA over the retina resulted in arteriolar vasoconstriction under basal conditions, but no alteration in the retinal arteriolar response to hypoxia, hypotension,or hypercarbia (Gidday & Zhu, 1995) . The findingsof these studies may have differed owing to species and anesthetic differences and may have been affected by, varying degrees of NOS inhibition. In summary, it appears that NO is a significant factor in the control of uveal circulation and is probably involved in regulation of retinal blood flow.
Physiological alterations in retinal and choroidal circulation
Few data are currently availableon the involvementof NO in mediating responses of the ocular circulation to physiological alterations, such as systemic hypoxia, hypercarbia, changes in perfusion pressure, or visual stimuli. In a preliminary study; retinai Wmodilationin response to hypoxia was not associated with release of NO (Pommmas et & 1993) . As in-t.he..cerebralcortex, increased retinal blood flow in response to hypoxia was attenuated by adenosine receptor blockade (Gidday & Park, 1993) . NOS blockade did not alter the retinal vascular responseto hypoxiain newborn pigs (Gidday & Zhu, 1995) .
During normoxic hypercapnia, retinal vessels dilated without an increase in NO release, and L-NA did not attenuate vasodilatation (Donati et al., 1994) . Similarly, L-NMAdid not attenuatethe retinal vascular responseto hypercarbia in newborn pigs (Gidday & Zhu, 1995) . Because NOS blockade may have been incomplete and the measurement of NO may not have been sufficiently sensitive in these investigations, further studies are necessary to confirm or deny NO involvement in the retinal vascular response to hypercapnia.
The retinal circulation autoregulates, and as a result, blood flowremainsrelativelyconstant,despitechangesin perfusion pressure (Aim & Bill, 1987) . ChemicaI messengers are believed to mediate this response, and the role of NO was examined in two preliminary studies in piglets.Local retinal administrationof L-NMAdid not alter the blood flow response to hypotension, and the investigatorsconcluded that NO was not responsiblefor autoregulation. However, retinal NOS activity was not measured, so it is possible that the results were due to inadequateNOS blockade (Gidday & Zhu, 1995) . In the second study, systemic administration of L-NAME reduced choroidal and retinal blood flow as perfusion pressure in the eye decreased (Jacot et al., 1994) . In a recent report, neurally derived NO was shown to be largely responsiblefor choroidalblood flow increases in responseto stimulationof the Edinger-Westphalnucleus in pigeons (Zagvazdinet al., 1996) .Further investigation is needed to clarify the role of NO in autoregulationin the retina.
Increased retinal blood flow in response to flickering white light flasheswas inhibitedin the presence of L-NA in a preliminarystudy,suggestinga role for NO in linking blood flow and visual transduction (Kondo et al., 1994) .
Post-ischemic hyperemia
After 60 min of ocular ischemia in cats induced by elevation of intraocular pressure, retinal blood flow measured with radioactive microsphere increased by over 300%,5 min after ischemiaended (Roth & Pietrzyk, 1994) .Choroidalflow was significantlyhyperperfusedas well. Blood flow was near pre-ischemic baseline 1 hr after ischemia ended. Although the relationshipbetween these blood flow changes and visual outcome has not yet been established,post-ischemichyperemia of the retinal circulationwas partiallyattenuatedby adenosinereceptor blockade (Roth, 1995) . Prior NOS inhibition using L-NAME eliminated the effect of adenosine receptor blockade . A possible explanation is that NOS blockade diminished pre-junctional NO attenuation of adenosine release, overcoming the effect of adenosine receptor blockade. Consistent with this hypothesis is the finding that, in the presence of NOS inhibition, adenosine release accompanying reactive hyperemia in the guinea pig heart was enhanced (Kostic & Schrader, 1992) .However, other mechanisms,such as NO effects upon cAMP release or NO and 02 free radical-inducedactivationof 5'-nucleotidasemay also be involved (Kitakaze et al., 1993) . NO appears to play a complex role in the blood flow changes that occur after retinal ischemia, but further work is necessary to clarify its involvementin the complex biochemicalchanges that accompany ischemia.
NITRIC OXIDEAND ISCHEMICDISEASEIN THE RETINA
Retinal ischemia occurs as a result of primary ocular disease, such as retinal vascular occlusion or as a consequence of systemic disease, such as diabetes mellitus. Excitatory amino acids (glutamate and aspartate) are involved in the initiation of ischemic damage (Zeevalk & Nicklas, 1990 ). Subsequently, increases in intracellular calcium and in oxygen free radical activity are believed to produce ultimate cell death by destruction of crucial cellular elements such as DNA, proteins, and the cell membrane (Choi, 1990) . NO may be significant in this pathway because of its interactionwith excitatory amino acid receptors; its role in free radical pathology; and its effects upon blood flow,neutrophilactivation,and platelet aggregation.
Nitric oxide and glutamate neurotoxicity
Under normal conditions, glutamate and aspartate released from nerve terminals are effectively taken up from the extracellular space (Schousboe, 1981) . When released in excess or if re-uptake is ineffective, as may occur in ischemia, the excitatory amino acids produce neurotoxicity (Lipton & Rosenberg, 1994) . Exposing chick retina to NMDA results in acute cell swelling and increased GABA release into the medium. If NMDA is removed from the medium, the swelling is eliminated, but delayed excitotoxicity occurs nonetheless, with degeneration of the amacrine cells and neurons of the ganglion layer (Zeevalk et al., 1989) . Acute neuronal injury results from swelling, induced by the opening of membrane cation channels, leading to Na+ influx, membrane depolarization,and osmotic influx of Cl-and water (Choi, 1987) . The more slowly evolving component depends on an influx of Ca2+and resultant enzyme activation (Choi, 1990) . Neurotoxicity with excessive Ca2+is more readily induced by low levels of glutamate and thus may predominate under many pathological conditions (Choi, 1987) .
Experimentally induced ischemia in isolated rat and rabbit retina stimulated a Ca2+-independentincrease in glutamate and aspartate of 100% after 30 min ischemia and a 15-to 20-fold increase after 90 min ischemia (Neal et al., 1994) . These findings are consistent with in vivo experiments in which glutamate receptor antagonists decreased ischemic damage in the retina (Tsukahara et al., 1992; Yoon & Marmor, 1989) . Once released, glutamate and aspartate bind to and stimulate NMDA receptors,increasingintracellularCa2+concentrationand stimulatingcNOS to produceNO (Bredt & Snyder, 1989; Garthwaite et al., 1988 Garthwaite et al., , 1989 .
The NO produced after release of glutamate may be a mediator of neurotoxicity.This hypothesiswas strongly supportedby studies of NO toxicity in rat fetal cortical, striatal, and hippocampalneurons (Dawson et al., 1991b . Neurotoxicity produced by administration of NMDA or sodium nitroprusside was similar in time course and dose-responseeffect. Further, neurotoxicity mediated by the calcium ionophore A23187 was Nondependent, as toxicity was attenuated by L-NA, hemoglobin, and L-arginine-freemedium. Calmodulinantagonists blocked neurotoxicity, indicating that Ca2+ neurotoxicity involves calmodulin and probably calmodulin-activated cNOS. Blockade of GC did not alter neurotoxicity by NMDA and, therefore, cGMP is probably not a mediator of toxicity. NOS expression in culture over time was coincident with NMDA-mediated cell death, and NOS was foundprimarily in processesand cell bodies of neurons (less than 1-2% of the total neuronalpopulationwas found to contain NOS). Several mechanisms are postulated for NO toxicity: NO-related damage to proteins, DNA, and membrane phospholipids, direct inactivationof mitochondrialenzymes, and energy depletion following activation of poly ADP ribose synthase after NO damage to DNA (Dawson, 1994) . NO stimulatesfurther release of excitatory amino acids, thereby providing excitatory amino acid upregulation duringischemia (Guevara-Guzmanet al., 1994; Imnart et al., 1992) . Preliminary studies indicate that NO also mediates glutamate toxicity in cultured retinal neurons (Kashii et al., 1994) .
In contrast to these findings, delayed cell death after exposure of embryonic chick retina to NMDA was not attenuatedby L-NA (Zeevalk & Nicklas, 1994) . In these experiments, glutamate, NMDA, and kainate stimulated two-to threefoldincreasesin cGMP, which were blocked by L-NAor by hemoglobin.Administrationof L-arginine partially reversed the L-NA-induceddecrease in cGMP. The lack of effect of NOS inhibitionon delayedcell death in the chick retina is probably due to predominance of other mechanisms in this species over NOS activation.
Endothelial damage and inducible nitric oxide synthase activation during ischemia and reperjitsion
Restoration of the circulation after ischemia leads to endothelialdysfunctionand the formation and activation of a multitudeof humoral mediatorsof inflammationand injury, includingoxygen-derivedfree radicals (hydrogen peroxide, superoxide, and hydroxyl radicals), lipid mediators (platelet activating factor and leukotrienes), and polypeptidemediators(e.g., C5a). Endothelialinjury with reduced NO, adenosine, and prostacyclin promotes inflammation and local injury through several mechanisms: vasoconstriction,platelet aggregation, and neutrophil adherence to the endothelium,all normally opposed by these substances (Lefer & Lefer, 1993) . Polypeptide mediators provide a signal for microphage and neutrophil aggregationand adherenceto the endothelium.Over time (minutes to hours) these mediators promote diapedesisof neutrophilsacross the endothelium (Lorant et al., 1991) . Pathologicalevidence of these phenomena after retinal ischemia has been detected. Erythrocytes, white blood cells, and fibrogranulardeposits have been found scattered throughout the retina after ischemia, usually localized to the inner layer (Anderson & Davis, 1975; Hughes, 1991; Johnson & Foulds, 1978; Shakib & Ashton, 1966) , along with trapped white blood cells within retinal vessels (Wilson & Hatchell, 1991) . In the later stages of reperfusion injury, these activated white blood cells could generate free radicals, which result in further, delayed tissue destruction (Rowe et al., 1984; Samuni et al., 1988) . Activated macrophagesand neutrophilscontain iNOS, which can generate large quantities of NO for several days, possibly another factor in delayed reperfusion damage. The activation of iNOS during or immediately after ischemia may stem from release of cytokines and may result in further toxic free radical formation (Morris & Billiar, 1994) . Cytokine levels may rise as a result of infiltration of macrophages or neutrophils into tissues during reperfusion (Lees, 1993) . Although free radical toxicity is involved in retinal ischemic damage, it is not currently known to what extent, if at all, iNOS activity contributes.If iNOS activationis involved,possiblesites for the origin of NO includewhite blood cells within the retinal circulation,iNOS-containingMuller glial cells, or the RPE. There is support for a theory that activated neutrophilsproduce NO via iNOS, from studies of focal or global cerebral ischemia.After occlusionof the middle cerebral artery in spontaneouslyhypertensiverats, iNOS mRNA was expressed starting at 12 hr, peaked at 48 hr, and returned to baseline by 7 days. iNOS immunoreactivity was detected in neutrophilsin the infarct zone at 48-96 hr after ischemia (Iadecola et al., 1995b) . In contrast, cNOS activity assayed in infarcted cerebral cortex in the same modeI of ischemia was significantly reduced at 1-7 days after ischemia (Iadecola et al., 1995a) . Seemingly contradicting these findings, iNOS immunoreactivity was detected in astrocytes, not neutrophils, after transient global cerebral ischemia (Endoh et al., 1994) .This result may be due to differencesin the pathophysiological mechanisms in these two different modelsof ischemia.However, all of these studiessuggest that activationof iNOS is a delayed event occurringlong after the onset of cerebral ischemia, and perhaps contributingto late cell death. Transgenic mice deficient in iNOS and thereby resistant to cardiovascularcollapse after injection of LPS have recently been developed (MacMicking et al., 1995) . Studies of ischemia in this model may help to further elucidate the role of iNOS in ischemic injury in the central nervous system. It has been speculated that iNOS activity may be responsible in part for diabetic vascular damage in the retina, as well as in other tissues, through NO-induced increases in blood flow and vascular permeability. In diabeticrats, 1251-labeled albuminentry acrossthe bloodretinal barrier, an indicator of altered vascular permeability, was decreased by chronic administration of guanidine compounds. Guanidines inhibit iNOS, suggesting that iNOS activity is increased in the diabetic retina. However, guanidines also inhibit advanced glycation end product (non-enzymatic glycation), believed also to be involvedin diabetic vascular complications (Tilton et al., 1993) . Since effects other than NOS inhibition may be mediated by these compounds, definitiveproof that NO producesdiabeticretinal damage is lacking.
Interaction of free radicalsand nitric oxide
Catabolism of purines via the xanthine oxidase pathway and metabolism of free fatty acids and arachadonic acid lead to the production of oxygen free radicals (hydrogen peroxide, H,O,; hydroxyl radical, OH-; and superoxide radical, 02-) either during or immediately after ischemia (Phillis, 1994) . Thus, hydroxyl (OH-) radical concentration increased significantly during reperfusion of ischemic cat retina (Ophir et al., 1993) . The burst of activated oxygen-derived, free radical speciesis responsiblefor pemxidationof cell membranes resulting in tissue edema, degradation of proteins and enzymes, and damage to DNA (Phillis, 1994) .
Physiologicalactions of NO are destroyedby 02-and stabilized by superoxide dismutase. Superoxide dismutase catalyzes the breakdown of 02- (Traystman et al., 1991) . Injection of L-NA into the vitreous of rabbits inhibited the protective effect of superoxide dismutase during and after ocular ischemia (Veriac et al., 1993) . The investigators speculated that NO may promote vasodilatation of ocular vessels after ischemia, a neuroprotective effect abolished by inactivation of NO when oxygen-derived free radicals are generated. Our group investigatedthe effect of NOS inhibitionadministered prior to retinal ischemia on ERG a-and b-wave recovery in cats . We found no significantdifference in recovery between L-NAME and a saline group. However, these findings are difficult to interpret due to the long-lasting depressive effects of NOS inhibitionon ERG wave amplitudes.Both our study and that of Veriac et al. did not examine other indices of ischemic damage. Perhaps functional and histopathological measurementswould be more usefulwhen studying the impact of NOS inhibition.
The administration of antioxidants may effectively enhance NO levels by decreasing the availabilityof free radicals to combine with NO to form other free radical species. The short-livedNO and the mildly reactive Ozcombine to form a potent and long-lived oxidant, peroxynitrite(ONOO-): 02-. + NO"-> ONOO- (Beckman et al., 1990; Blough & Zafiriou, 1985; Koppenol et al., 1992) . A vicious circle ensues, whereby ONOObreaks down to OH-, lipid peroxidation occurs, with subsequentformationof free fatty acids, followed in turn by further free radical formation (Beckman, 1991; Traystman et al., 1991) .
As mentionedpreviously,NO may have either toxic or neuroprotectiveeffects in ischemia.This paradox may be explained by the redox state assumed by NO. NO may exist under physiological conditions as the free radical nitrogen monoxide (NO., where the . symbolizes an unpaired electron) or the cation nitrosonium (NO+) (Stamler et al., 1992) . Nitric oxide is believed to be neurotoxicif the redox state of the tissuefavorsformation of NO. and neuroprotective if the medium favors NO+ formation (Lipton et al., 1993) .Neurotoxiceffects of NO may be mediated through ONOO-formation, whereas the neuroprotectiveeffect of nitrosoniummay stem from nitrosylation and deactivation of NMDA receptors, inhibitingfurtherNMDA-mediatedneurotoxicity (Lipton et al., 1993) . Consistentwith a possible neuroprotective effect of NO+ in the retina was the finding that sodium nitroprusside significantly decreased NMDA-induced currents in cultured rat retinal neurons (Ujihara et al., 1993) .
Nitric oxide: Neurotoxic or neuroprotective?
If modulation of NO concentration is to play a therapeutic role in retinal ischemia, it is important to determine when and how to alter its concentration, as well as the relative activity of cNOS and iNOS. In a preliminary study, cNOS gene expression decreased to 10% of baseline level 12-96 hr after the end of 2 hr of retinal ischemia in rats. Expression of iNOS increased 20-fold at 12 hr after the end of ischemia (Hangai et al., 1994) .These findingsresemble those of cNOS and iNOS expression after focal cerebral ischemia (Iadecola et al., 1995a, b) . Protection of the retina from light damage using a NOS inhibitorhas been reported (Goureau et al., 1993a) . A recent report suggests a protective effect of NOS inhibitionafter retinal ischemiain rats (Geyer et al., 1995) .
To examine the role of NO in c~rebral ischemia, studies have been performed to decrease NO concentration using NOS inhibition,or to increase NO concentration by administering NO donors such as sodium nitroprusside . Whether NOS inhibition is beneficial or harmful to the outcome of cerebral ischemia is controversial; some studies have shown improvement in ischemic outcome, others worsening.Varyingresultsmay be due to speciesdifferences, differing ischemia models, or differences in the agents used to inhibit NOS, as well as the timing of NOS inhibition relative to ischemia (Pelligrino, 1993) . The controversy may derive from differing effects of NO at various stages of ischemic injury. This issue has been examined in detail in transgenic mice deficient in neuronal NOS (Huang et al., 1994) . The mice demonstrated gastrointestinal abnormalities(resemblinghuman pyloric stenosis) and, in males, sexually aggressive behavior (Huang et al., 1993; Nelson et al., 1995) .In these genetically altered mice, infarct volume following middle cerebral artery occlusion was lower than in nonmutants, despite similar reductions in regional cerebral blood flow. The "additionof L-NA to inhibit endothelial NOS resulted in an increase in infarct size. These results indicate that neuronal NOS worsens acute ischemic injury, probably through delayed production of NO with its attendant inflammatoryeffects. Release of NO in the vasculature (by endothelial NOS) is a beneficial effect probably due to increased blood flow to ischemic areas. Therefore, specific inhibitors of neuronal NOS given at the appropriatetime points could be of potential clinical use in a setting of cerebral ischemia.
CONCLUSIONS
Although many questions remain, a large number of studieshave examinedthe diverserole of NO in the brain in controlof blood flow, neurotransmission,and involvement in ischemia. NO in the retina is now receiving increased attention. NOS has been found in most of the retina. Current evidence indicates that NO is involved in maintaining resting tone in the uveal and retinal circulations.After ischemia,NO may be involvedin the pathogenesis of reperfusioninjury. NO is known to participate in excitatory amino acid-and free radical-mediated reperfusion injury after ischemia in the brain, although data are now beginning to appear about its effects.
NO appears to play a role in the visual transduction system. NO stimulation of soluble guanylate cyclase stimulatescGMP production in photoreceptorsand, to a greater extent, in bipolar cells. It is likely that NO is a neurotransmitterwithin the retina, but its significancein visual transduction has not been fully elucidated. Much remains to be learned about NO and NOS in the retina. It is likely that the importance of NO in the retina will become better clarified in the near future.
